Radius Health, Inc. RDUS announced positive top-line data from the phase III ATOM study which is evaluating its lead product, Tymlos (abaloparatide 80 mg subcutaneous [“SC”]) injection, for use in men ...

Tymlos can cause mild to serious side effects. Examples include dizziness, injection site reaction, and nausea. In most cases, side effects caused by Tymlos are temporary. For most people, mild side ...